A pilot study to assess the incidence of local oropharyngeal and laryngeal adverse effects of Advair Diskus [salmeterol/fluticasone propionate] 250/50 mcg BID as assessed by the development of laryngitis and oropharyngeal candidiasis in adults with mild persistent asthma

Trial Profile

A pilot study to assess the incidence of local oropharyngeal and laryngeal adverse effects of Advair Diskus [salmeterol/fluticasone propionate] 250/50 mcg BID as assessed by the development of laryngitis and oropharyngeal candidiasis in adults with mild persistent asthma

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Jan 2017

At a glance

  • Drugs Salmeterol/fluticasone propionate (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top